UTEP Study Examines COVID-19 Stress, Coping Strategies, and Well-Being

University of Texas at El Paso

Newswise — EL PASO, Texas – Active coping, denial, emotional support, humor and religion are among the coping strategies that help people with chronic conditions and disabilities deal with stress caused by the COVID-19 pandemic, according to a recently published study written by researchers at The University of Texas at El Paso. 

Emre Umucu, Ph.D., assistant professor of rehabilitation counseling, and Beatrice Lee, an incoming rehabilitation counseling faculty member, examined the perceived stress levels and coping mechanisms related to COVID-19, and how coping affects well-being in people with self-reported chronic conditions and disabilities. 

Umucu said their exploratory work has provided some preliminary information on how these individuals perceive COVID-19 and how the coping strategies they are using are related to their well-being. 

Their findings were recently published in the Rehabilitation Psychology. 

“Given that COVID-19 is a new and highly evolving stressor for everyone, especially for people with chronic conditions and disabilities, it is important to understand how individuals cope with it,” said Umucu, director of UTEP’s Veteran VVell-Being Lab (V3​). “Measuring and quantifying COVID-19-related stress and coping strategies in individuals with chronic conditions and disabilities can help clinicians and researchers understand the potential negative effects of COVID-19 among people with chronic conditions and disabilities.” 

Findings from the study may help clinicians, researchers and policymakers gain a better understanding of the use of coping strategies in individuals with chronic conditions and disabilities facing the pandemic. Learn more here: https://pubmed.ncbi.nlm.nih.gov/32406739/?from_term=%22umucu%22&from_filter=years.2020-2020&from_pos=4

Umucu joined UTEP in 2017. His research interests include veterans, positive psychology interventions, mental health, substance use disorders, severe mental illnesses, happiness, resilience, well-being, aging, and psychometrics and test construction. Lee is a 2020 graduate from the University of Wisconsin-Madison’s Rehabilitation Counselor Education Ph.D. program. She will start at UTEP in the fall 2020 semester. 

UTEP Master of Rehabilitation Counseling (MRC) Program trains future rehabilitation counselors who provides rehabilitation and mental health counseling services to people with chronic conditions and disabilities.




Filters close

Showing results

110 of 4573
Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.


Showing results

110 of 4573

close
1.30693